Nyxoah S.A. ( NYXH) - Key Metrics
NYXH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.14 | -$0.59 | ? | ? |
| 2025Q3 | $0.05 | -$0.63 | -$0.55 | -$0.55 |
| 2025Q2 | $0.04 | -$0.55 | -$0.45 | -$0.46 |
| 2025Q1 | $0.03 | -$0.60 | -$0.49 | -$0.50 |
NYXH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -1.67 |
| 2025Q3 | ? | -1.56 |
| 2025Q2 | ? | -2.88 |
| 2025Q1 | ? | -2.70 |
NYXH
Price: $1.40
52 week price:
Earnings Per Share: -2.50 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: Belgium
Volume: 11600
Market Capitalization: 58.3 million